Abstract
Data were analysed on 33 children (22 males) with Silver Russell syndrome treated with growth hormone for periods up to 5 years. Baseline data (medians) at commencement of growth hormone (GH) therapy were age 6.7 years, bone age delay 1.7 years, height standard deviation score (SDS)-3.2, weight SDS −3.1, and growth velocity 5.7 cm/year. All were prepubertal. Median birth weight SDS for gestational age was −3.2. GH was commenced at 14 IU/m2 per week and subsequently adjusted according to response. Growth velocity and growth velocity SDS for chronological age (CA) improved over baseline and gains in height SDS for CA were 1.0, 1.5 and 1.8 SD over 3, 4 and 5 years respectively (P < 0.001). No significant increase in height SDS for bone age was observed. Increased GH doses were required after the 1st year to maintain growth rates. Mean bone age advancement was 3.1 years after 3 years of treatment, and 6.0 years after 5 years treatment. Younger age was a predictor of the growth response over the 1st year. Predictors of response after 3 years were catch-up growth, low weight SDS at birth and low height SDS for CA. Age at onset of puberty was normal, but height at onset of puberty was lower than normal means.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- BA :
-
bone age
- CA :
-
chronological age
- EMH :
-
estimated mature height
- GH :
-
growth hormone
- GV :
-
growth velocity
- IUGR :
-
intrauterine growth retardation
- MPH :
-
mid-parental height
- SDS :
-
standard deviation score
- SRS :
-
Silver Russell syndrome
References
Albanese A, Stanhope R (1993) Growth and metabolic data following treatment of children with intrauterine growth retardation. Horm Res 39:8–12
Albertsson-Wikland K (1989) Growth hormone secretion and growth hormone treatment in children with intrauterine growth retardation. Acta Paediatric Scand [Suppl] 349:35–41
Albertsson-Wikland K, Kallberg J (1994) Natural growth in children born small for gestational age with and without catch-up growth. Acta Paediatr Scand [Suppl] 343:23–30
Angehrn V, Zachmann M, Prader A (1979) Silver-Russell syndrome, observation in 20 patients. Helv Paediatr Acta 34:397–308
Balsamo A, Tassoni P, Cassio A, Colli C, Tassinari D, Cicognani A, Cacciari E (1995) Response to growth hormone therapy in patients with growth hormone deficiency who at birth were small or appropriate in size for gestational age. J Pediatr 126:474–477
Buckler J (1990) A longitudinal study of adolescent growth. Springer, Berlin Heidelberg New York London
Bundiak R, Hindmarsh PC, Smith PJ, Brook CG (1988) Long term auxologic effects of human growth hormone. J Paediatr 112:875–879
Chatelain PG (1993) Auxology and response to growth hormone treatment of patients with intrauterine growth retardation or Silver Russell syndrome: analysis of data from the Kabi pharmacia International Growth Study. Acta Paediatric Scand [Suppl] 391:79–81
Chatelain P, Nicolino M (1994) Intrauterine growth retardation and Silver Russell Syndrome:demography, auxulogy and response to growth hormone treatment in the Kabi International Growth Studies. In:Ranke MB, Gunnarsson R (eds) Progress in Growth hormone therapy - 5 years of KIGS. J and J Verlag, Hannheim, pp 230–239
Cowell CT, Wilcox L, Moore B, Likitmaskul S (1993) The effects of growth hormone beyond the first year in non growth hormone deficient children. In: Cowell CT, Ho KKY, Werther GA (eds) Growth and sexual development. Harwood Academic, Switzerland, pp 91–102
Cowell CT, Dietsch S, Greenacre P. Growth hormone deficient and non growth hormone deficient children: The OZGROW experience. (in press)
Davies PSW, Valley R, Preece MA (1988) Adolescent growth and pubertal progression in the Silver-russell syndrome. Arch Dis Child 63:130–135
Duncan PA, Hall JG, Shapiro LR, Vibert BK (1990) Three-generation dominant transmission of the Silver-Russell syndrome. Am J Med Genet 35:245–250
Escobar V, Gleiser S, Weaver DD (1978) Phenotypical and genetic analysis of the Silver-Russell Syndrome. Clin Genet 13:278–288
Greulich WW, Pyle SI (1959) Radiographic atlas of skeletal development of the hands and wrist 2nd ed. Stanford University Press, Palo Alto, California
Hamill PRV, Drizd TA, Johnson CL, Reed PR, Roche AF (1977) NCHS growth curves for children from birth to 18 years. DHEW publication no. (PHS) 78-1650, United States, 165:1–74
Niklasson A, Ericson A, Fryer JG, Karlberg J, Lawrence C, Karlberg P (1991) An update of the Swedish reference standards for weight, length and head circumference at birth for given gestational age (1977–1981). Acta Paediatr Scand 80:756–762
Patton MA (1988) Russell-Silver Syndrome. J Med Genet 25:557–560
Ranke MB, Stubbe P, Majewski F, Bierich JR (1988) Spontaneous growth in Turner's syndrome. Acta Paediatr Scand [Suppl] 343:22–30
Ranke MB, Guilbaud O, Lindberg A, Cole T (1993) Prediction of the growth response with various growth disorders treated with growth hormone: analyses of data from the Kabi Pharmacia International Growth Study. Acta Paediatr Scand [Suppl] 391:82–88
Russell A (1954) A syndrome of intrauterine dwarfism, recognisable at birth with craniofacial dysostosis, disproportionately short arms and other anomalies (5 examples). Proc Roy Soc Med 117:1040–1044
Saal HM, Pagon RA, Pepin MG (1985) Reevaluation of Russell-Silver Syndrome. J Paediatr 107:533–737
Silver HK (1964) Asymmetry, short stature and variations in sexual development. A syndrome of congenital malformations. Am J Dis Child 107:495–513
Silver HK, Kiyasu W, George J, Deamer WC (1953) Syndrome of congenital hemihypertrophy, shortness of stature and elevated urinary gonadotropins. Pediatrics 12:368–375
SPIDA version [computer program] (1993) Sydney: Statistical Computing Laboratory, Macquarie University
Stanhope R, Hamill AG, Clayton J, Jones J, Preece MA (1989) Physiological growth hormone secretion and response to growth hormone treatment in children with short stature and intrauterine growth retardation. Acta Paediatr Scand [Suppl] 349:47–52
Stanhope R, Preece MA, Hamill G (1991) Does growth hormone treatment improve final height attainment of children with intrauterine growth retardation? Arch Dis Child 66:1180–1183
Tanaka T (1994) Pubertal aspects of idiopathic growth hormone deficiency. In:Ranke MB, Gunnarsson R (eds) Progress in growth hormone therapy - 5 years of KIGS. J and J Verlag, Mannheim, pp 112–128
Tanner JM, Davis PSW (1985) Clinical longitudinal standards for height and height velocity for North American children. J Paediatr 107:317–329
Tanner JM, Lejarraga H, Cameron N (1975) The natural history of the Silver-Russell syndrome: a longitudinal study of thirty-nine cases. Paediatr Res 9:611–623
Wallis S, Harvey DR (1980) Small-for dates babies, their problems and their future in:Wharton BA (ed) Topics in perinatal medicine. Pitman Medical, London, pp 50–63
Author information
Authors and Affiliations
Consortia
Rights and permissions
About this article
Cite this article
Rakover, Y., Dietsch, S., Ambler, G.R. et al. Growth hormone therapy in Silver Russell Syndrome: 5 years experience of the Australian and New Zealand Growth database (OZGROW). Eur J Pediatr 155, 851–857 (1996). https://doi.org/10.1007/BF02282833
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02282833